Stephen F. Carter

3.4k total citations
41 papers, 2.0k citations indexed

About

Stephen F. Carter is a scholar working on Physiology, Psychiatry and Mental health and Neurology. According to data from OpenAlex, Stephen F. Carter has authored 41 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Physiology, 26 papers in Psychiatry and Mental health and 14 papers in Neurology. Recurrent topics in Stephen F. Carter's work include Alzheimer's disease research and treatments (26 papers), Dementia and Cognitive Impairment Research (26 papers) and Neurological Disease Mechanisms and Treatments (11 papers). Stephen F. Carter is often cited by papers focused on Alzheimer's disease research and treatments (26 papers), Dementia and Cognitive Impairment Research (26 papers) and Neurological Disease Mechanisms and Treatments (11 papers). Stephen F. Carter collaborates with scholars based in United Kingdom, Sweden and United States. Stephen F. Carter's co-authors include Agneta Nordberg, Michael Schöll, Anders Wall, Ove Almkvist, Bengt Långström, Karl Herholz, K. Herholz, Matthew Jones, Elena Rodriguez‐Vieitez and Henry Engler and has published in prestigious journals such as SHILAP Revista de lepidopterología, NeuroImage and Brain.

In The Last Decade

Stephen F. Carter

40 papers receiving 2.0k citations

Peers

Countries citing papers authored by Stephen F. Carter

Since Specialization

Citations

This map shows the geographic impact of Stephen F. Carter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen F. Carter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen F. Carter more than expected).

Fields of papers citing papers by Stephen F. Carter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen F. Carter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen F. Carter. The network helps show where Stephen F. Carter may publish in the future.

Co-authorship network of co-authors of Stephen F. Carter

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen F. Carter. A scholar is included among the top collaborators of Stephen F. Carter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen F. Carter. Stephen F. Carter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Polygenic risk discriminates Lewy body dementia from Alzheimer's disease 2025 ·Alzheimer s & Dementia ·(unknown), (unknown), Maura Malpetti, Paul C. Donaghy, Alan Thomas, Elijah Mak, Stephen F. Carter, Jun Tan, Young T. Hong, Tim D. Fryer, Amanda Heslegrave, Henrik Zetterberg, Li Su, Leonidas Chouliaras, James B. Rowe, John T. O’Brien	0
2	Brain age gap, dementia risk factors and cognition in middle age 2024 ·Brain Communications ·James D. Stefaniak, Elijah Mak, Li Su, Stephen F. Carter, Maria‐Eleni Dounavi, Graciela Muñiz‐Terrera, (unknown), (unknown), Brian Lawlor, Lorina Naçi, Ivan Koychev, Paresh Malhotra, Karen Ritchie, John T. O’Brien	3
3	Evaluation of in vivo staging of amyloid deposition in cognitively unimpaired elderly aged 78–94 2022 ·Molecular Psychiatry ·(unknown), Karl Herholz, Rainer Hinz, (unknown), Lynn McInnes, José Anton‐Rodriguez, Thomas K. Karikari, Kaj Blennow, Henrik Zetterberg, Nicholas J. Ashton, Neil Pendleton, Stephen F. Carter	9
4	CAIDE dementia risk score relates to severity and progression of cerebral small vessel disease in healthy midlife adults: the PREVENT-Dementia study 2022 ·Journal of Neurology Neurosurgery & Psychiatry ·Audrey Low, (unknown), James D. Stefaniak, (unknown), Stephen F. Carter, (unknown), Elijah Mak, Li Su, (unknown), Graciela Muniz, Karen Ritchie, Craig Ritchie, Hugh S. Markus, John T. O’Brien	20
5	Modifiable and non-modifiable risk factors of dementia on midlife cerebral small vessel disease in cognitively healthy middle-aged adults: the PREVENT-Dementia study 2022 ·Alzheimer s Research & Therapy ·Audrey Low, (unknown), (unknown), Stephen F. Carter, James D. Stefaniak, Stefania Nannoni, Li Su, Maria‐Eleni Dounavi, Graciela Muñiz‐Terrera, Karen Ritchie, Brian Lawlor, Lorina Naçi, Paresh Malhotra, Clare E. Mackay, Ivan Koychev, Craig Ritchie, Hugh S. Markus, John T. O’Brien	17
6	Proximity to dementia onset and multi-modal neuroimaging changes: The prevent-dementia study 2021 ·NeuroImage ·Elijah Mak, Maria‐Eleni Dounavi, Audrey Low, Stephen F. Carter, (unknown), Guy Williams, P. Simon Jones, Isabelle Carrière, Graciela Muniz, Karen Ritchie, Craig Ritchie, Li Su, John T. O’Brien	9
7	Astrocyte Biomarkers in Alzheimer Disease 2021 ·Neurology ·Bruna Bellaver, João Pedro Ferrari‐Souza, (unknown), Stephen F. Carter, Elena Rodriguez‐Vieitez, Agneta Nordberg, Luc Pellerin, Pedro Rosa‐Neto, Douglas Teixeira Leffa, Eduardo R. Zimmer	80
8	Gray matter changes related to microglial activation in Alzheimer's disease 2020 ·Neurobiology of Aging ·Nicolas Nicastro, Maura Malpetti, Elijah Mak, Guy Williams, W Richard Bevan‐Jones, Stephen F. Carter, Luca Passamonti, Tim D. Fryer, Young T. Hong, Franklin I. Aigbirhio, James B. Rowe, John T. O’Brien	18
9	Imaging tau burden in dementia with Lewy bodies using [18F]-AV1451 positron emission tomography 2020 ·Neurobiology of Aging ·Elijah Mak, Nicolas Nicastro, Maura Malpetti, George Savulich, Ajenthan Surendranathan, Negin Holland, Luca Passamonti, P Simon Jones, Stephen F. Carter, Li Su, Young T. Hong, Tim D. Fryer, Guy Williams, Franklin I. Aigbirhio, James B. Rowe, John T. O’Brien	21
10	11C-UCB-J synaptic PET and multimodal imaging in dementia with Lewy bodies 2020 ·SHILAP Revista de lepidopterología ·Nicolas Nicastro, Negin Holland, George Savulich, Stephen F. Carter, Elijah Mak, Young T. Hong, Selena Milicevic Sephton, Tim D. Fryer, Franklin I. Aigbirhio, James B. Rowe, John T. O’Brien	21
11	Prognostic value of Alzheimer’s biomarkers in mild cognitive impairment: the effect of age at onset 2019 ·Journal of Neurology ·(unknown), Daniele Altomare, Clarissa Ferrari, Anna Caroli, Samantha Galluzzi, Annapaola Prestia, Wiesje M. van der Flier, Rik Ossenkoppele, Bart van Berckel, Frederik Barkhof, Charlotte E. Teunissen, Anders Wall, Stephen F. Carter, Michael Schöll, Il Han Choo, Timo Grimmer, Alberto Redolfi, Agneta Nordberg, Philip Scheltens, Alexander Drzezga, Giovanni B. Frisoni	11
12	Astrocyte Biomarkers in Alzheimer’s Disease 2019 ·Trends in Molecular Medicine ·Stephen F. Carter, Karl Herholz, Pedro Rosa‐Neto, Luc Pellerin, Agneta Nordberg, Eduardo R. Zimmer	227
13	Dual-phase [18F]florbetapir in frontotemporal dementia 2018 ·European Journal of Nuclear Medicine and Molecular Imaging ·(unknown), Rainer Hinz, Karl Herholz, Stephen F. Carter	14
14	Longitudinal association between astrocyte function and glucose metabolism in autosomal dominant Alzheimer’s disease 2018 ·European Journal of Nuclear Medicine and Molecular Imaging ·Stephen F. Carter, Konstantinos Chiotis, Agneta Nordberg, Elena Rodriguez‐Vieitez	43
15	Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer’s disease 2016 ·Brain ·Elena Rodriguez‐Vieitez, Laure Saint‐Aubert, Stephen F. Carter, Ove Almkvist, Karim Farid, Michael Schöll, Konstantinos Chiotis, Steinunn Þórðardóttir, Caroline Graff, Anders Wall, Bengt Långström, Agneta Nordberg	208
16	Comparison of Early-Phase ¹¹C-Deuterium-l-Deprenyl and ¹¹C-Pittsburgh Compound B PET for Assessing Brain Perfusion in Alzheimer Disease 2016 ·Journal of Nuclear Medicine ·Elena Rodriguez‐Vieitez, Stephen F. Carter, Konstantinos Chiotis, Laure Saint‐Aubert, Antoine Leuzy, Michael Schöll, Ove Almkvist, Anders Wall, Bengt Långström, Agneta Nordberg	58
17	Early astrocytosis in autosomal dominant Alzheimer’s disease measured in vivo by multi-tracer positron emission tomography 2015 ·Scientific Reports ·Michael Schöll, Stephen F. Carter, Eric Westman, Elena Rodriguez‐Vieitez, Ove Almkvist, Steinunn Þórðardóttir, Anders Wall, Caroline Graff, Bengt Långström, Agneta Nordberg	106
18	Regional Neuronal Network Failure and Cognition in Late-Onset Sporadic Alzheimer Disease 2014 ·American Journal of Neuroradiology ·Stephen F. Carter, Karl V. Embleton, José Anton‐Rodriguez, Alistair Burns, Matthew A. Lambon Ralph, Karl Herholz	13
19	Comparison of MRI based and PET template based approaches in the quantitative analysis of amyloid imaging with PIB-PET 2012 ·NeuroImage ·Paul Edison, Stephen F. Carter, Juha O. Rinne, Giorgio Gelosa, Karl Herholz, Agneta Nordberg, David J. Brooks, Rainer Hinz	44
20	Evidence for Astrocytosis in Prodromal Alzheimer Disease Provided by ¹¹ C-Deuterium-L-Deprenyl: A Multitracer PET Paradigm Combining ¹¹ C-Pittsburgh Compound B and ¹⁸ F-FDG 2012 ·Journal of Nuclear Medicine ·Stephen F. Carter, Michael Schöll, Ove Almkvist, Anders Wall, Henry Engler, Bengt Långström, Agneta Nordberg	326

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact